Skip to main
TVGN

TVGN Stock Forecast & Price Target

TVGN Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Tevogen is facing multiple challenges that are impacting its stock price, including dilution risk and a recently announced 50:1 reverse stock split. These decisions have led to a decrease in our price target and a downgrade from Buy to Hold in our rating. Despite these issues, we still have a positive outlook on the company due to its focus on biotechnology, AI, and technology in the healthcare industry, which holds strong potential for growth and success in the future.

Bears say

Tevogen is significantly diluting its existing shareholders with the reverse stock split, leading to reduced liquidity and a shrinking shareholder base. Additionally, the company faces multiple risks in its various business segments, including clinical/regulatory, financial, commercial, legal and intellectual property, and market share risks, which may further impact its financial performance and the sentiment around the company. The potential acquisition of a contract research organization may bring strategic and financial benefits, but there is no assurance of completion, and the company is also investing in other areas, such as Tevogen.AI, suggesting a lack of focus and potential for further dilution and financial risks.

TVGN has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Semper Paratus Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Semper Paratus Acquisition Corp (TVGN) Forecast

Analysts have given TVGN a Strong Buy based on their latest research and market trends.

According to 1 analysts, TVGN has a Strong Buy consensus rating as of Aug 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Semper Paratus Acquisition Corp (TVGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.